Hello.
Arkansas Children's Hospital
General Information 501-364-1100
Arkansas Children's Northwest
General Information 479-725-6800
A Phase 2/3 Safety, Pharmacokinetics, and efficacy study of Nirmatrelvir/Ritonavir in pediatric, non-hospitalized symptomatic participants with COVID-19 who are at risk of progression to severe disease.